Sie befinden Sich hier: FORUM > Regulatory-Affairs > Our Seminars

Therapeutic Antibodies

From Originators...

  • Essential quality data for first-in-human clinical trials up to the marketing authorisation
  • Risk assessment and mitigation for first-in-human studies
  • Management of side effects & immunogenicity as a safety issue

...To Biosimilars

  • Quality: laying the foundation for biosimilarity
  • Update on progress of EU/US guidelines
  • Practical considerations on designing biosimilar clinical studies
  • Current regulatory thinking on extrapolation of indications

Please click here for detailed information on Therapeutic Antibodies.

 

 

RUSSIA: Registration of Generics and Biosimilars

Key topics:

    • Legal background for a generic registration
    • Current challenges in biosimilar registrations
    • Dossier and registration process
    • Local bioequivalence studies according to the new Russian guidelines

     Please click here for detailed information on RUSSIA: Registration of Generics and Biosimilars

     

     

    FDA: Marketing Authorisation in the U.S.

    Key topics:

      • US FDA regulations in comparison with the EU law
      • The FDA drug registration in detail
      • Communication with the FDA
      • Marketing authorisation granted - the arising duties
      • Case Study - how FDA approves oncological products

       Please click here for detailed information on FDA: Marketing Authorisation in the U.S.

       

       

      Regulatory Affairs India

      Key topics:

        • The authorities' system
        • New drug registration regulation
        • Generics drug registration
        • Post-approval regulatory processes

        Please click here for detailed information on Regulatory Affairs India.

         

         

        Regulatory Affairs China

        Key topics:

          • The CFDA and further authorities, agencies & ministries
          • Documents for the application
          • Maintenance of the licence
          • IP protection

          Please click here for detailed information on Regulatory Affairs China.

           

           

          Marketing Authorisation for human medicines in Latin America

          Focus: Brazil, Argentina, Colombia & Mexico

          Key topics:

          • Legal framework & national authorities
          • National marketing authorisation procedures
          • Dossier requirements in Latin America
          • Maintenance of the marketing authorisation

          Please click here for detailed information on Marketing authorisation in Latin America.

           

           

          Marketing Authorisation in ASIA

          Key Topics:

          • Current regulatory framework in the Asian countries
          • ASEAN: Harmonisation of the Asian drug market?
          • China - guidelines and marketing authorisation
          • Marketing authorisation for NCEs and generics
          • Submission of variations and renewals
          • Communication with the authorities

          Please click here for detailed information on Marketing Authorisation in ASIA

           

           

          Marketing Authorisation in the Middle East

          Key Topics:

            • Market entry in the region - lucrative countries and regulatory strategy
            • New regulation regarding regulatory affairs and pharmacovigilance
            • Oman - interesting for your products?
            • GCC - necessary documents and approval process
            • Pharmacovigilance duties in the Middle East

            Please click here for detailed information on Marketing Authorisation in the Middle East

             

             

            Scientific Writing and Reviewing in Regulatory Affairs

            Key Topics:

            • Free writing versus regulatory restrictions
            • Writing and reviewing regulatory documents
            • Editing and proofreading documents
            • Package leaflet - regulatory linguistic restrictions and user-friendly writing
            • Good writing skills - example: clinical overviews and summaries

            Please click here for detailed information on Scientific Writing and Reviewing in Regulatory Affairs

             

             

            Marketing authorisation in North & South Africa

            Regulatory Update - The Maghreb Countries & South Africa

            Key topics:

            • Marketing authorisation dossier requirements
            • Key persons in the countries
            • Communication with the national authorities
            • Maintenance and product information duties - variations and labelling

            Please click here for detailed information on Marketing authorisation in North & South Africa.

             

             

            Marketing Authorisation in Turkey and the CAC Countries

            Key topics:

              • Access to the local markets - preconditions for companies
              • Application dossier requirements
              • Further obligations: GMP, clinical trials and vigilance
              • Application procedures for NCEs, generics, biosimilars ...
              • Maintenance duties - renewals and variations

              Please click here for detailed information on Marketing Authorisation in Turkey and the CAC Countries.

              MR & Decentralised Procedure - Your Regulatory Strategy

              Key topics:

                • Essential points in the presubmission phase
                • The submission: country specialities!
                • Multiple/duplicate applications - with case studies
                • Delaying and accelerating factors
                • E-Submission - eAF & CESP

                Please cklick here for detailed information on MR & Decentralised Procedure - Your Regulatory Strategy